Pfizer’s Chief Executive Albert Bourla is betting on one area for new growth: Non-Covid vaccines. The executive said in an interview Tuesday that after [revising Pfizer’s sales outlook](https://ift.tt/xVJLO26) on its [Covid-19 products](https://ift.tt/zr3IDZ2), the rest of the company’s business is in position to help drive growth. Pfizer this year won two regulatory approvals for [the RSV shot](https://ift.tt/0U87FlO), one [for pregnant women to protect their newborns](https://ift.tt/3PHrIQa), and one for older adults.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles